ANGO
AngioDynamics
–
Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;
Marketcap: 457.13M; Volume: 251.85K; AvgVol 3m: 304.13K; Beta: 0.50;
Cost estimate:
P/E: –; EPS: -4.38; EPS growth quarter/prev quarter: ;
EPS growth this year: -77.80%; EPS growth past 5 years: 4.38%;
EPS ttm: -4.46;
P/S: 1.64; P/B: 0.97; P/Cashflow: ; P/FCF: ;
Sales: 264.15M; Sales growth quarter/prev quarter: -18.10%; Sales growth past 5 years: -5.80%;
Profitability:
Gross Margin: 55.10%; Profit Margin: 18.30%; Operating Margin: -2.80%;
ROA – return on assets: 7.20%; ROE – return on equity: 8.60%; LT Debt/Equity: 0.09; Total Debt/Equity: 0.09;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 2.60%; Insider Transactions:4.36%;
Institutional Ownership: 98.20%; Institutional Transactions: -0.62%;
Data update: 07/10/2020.